A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib / 대한소화기학회지
The Korean Journal of Gastroenterology
; : 366-369, 2015.
Article
em En
| WPRIM
| ID: wpr-223601
Biblioteca responsável:
WPRO
ABSTRACT
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Imatinib mesylate is recommended as adjuvant therapy for GIST after surgical resection. However, drug-related adverse events are common. A 74-year-old female with metastatic GIST who was managed with imatinib experienced severe adverse events, including skin rashes, tremor, and alopecia, etc. The imatinib dose was reduced and the size of the metastatic GIST continued to decrease and adverse events showed significant improvement.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Imuno-Histoquímica
/
Tomografia Computadorizada por Raios X
/
Proteínas Proto-Oncogênicas c-kit
/
Tumores do Estroma Gastrointestinal
/
Exantema
/
Mesilato de Imatinib
/
Neoplasias Gastrointestinais
/
Antineoplásicos
Limite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
The Korean Journal of Gastroenterology
Ano de publicação:
2015
Tipo de documento:
Article